The use of an AI-powered risk assessment tool cut the average length of stay for patients undergoing cardiac catheterization with percutaneous coronary intervention, or angioplasty, in half, according to a study published March 18 in the Journal of the Society for Cardiovascular Angiography & Interventions.
The study is part of JSCAI’s special issue, “The Role of Artificial Intelligence in Cardiovascular Interventions,” a March 18 press release from the organization said.
Here are five notes on the study’s findings:
1. Researchers from Kettering (Ohio) Health conducted a retrospective analysis of 642 patients who had undergone cardiac catheterization with PCI between April 2023 and March 2024 for the study.
2. Every patient included in the analysis received the AI-powered risk assessment and the maximum recommended contrast volume dose, the study said.
3. The incidence of contrast-induced acute kidney injury, one of the most frequent complications from PCI, declined from 10% to an average of 2.18%. Of patients who did experience contrast-induced acute kidney injury, 92.9% occurred during hospitalization.
4. The incidence of bleeding complications declined from 2.15 events per month to an average of 1.54 events per month.
5. Patients’ average length of stay declined from 3.44 days to 1.79 days.
Read the full study here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
